- 全部删除
您的购物车当前为空
BET-IN-26 (compound 13a) 是一种高效、选择性且可口服的BD1抑制剂,其对BD1和BD2的IC50值分别为0.0055 µM和9.0 µM。BET-IN-26 能够降低LPS诱导的血清IL-6和MCP-1水平。
BET-IN-26 (compound 13a) 是一种高效、选择性且可口服的BD1抑制剂,其对BD1和BD2的IC50值分别为0.0055 µM和9.0 µM。BET-IN-26 能够降低LPS诱导的血清IL-6和MCP-1水平。

BET-IN-26 相关产品
| 产品描述 | BET-IN-26 (compound 13a) is a potent, selective, and orally active BD1 inhibitor, exhibiting IC50 values of 0.0055 µM for BD1 and 9.0 µM for BD2. It effectively reduces serum IL-6 and MCP-1 levels induced by LPS. |
| 靶点活性 | BD1:0.0055 μM, BD2:9.0 μM |
| 体内活性 | BET-IN-26 (compound 13a) 在小鼠体内以剂量依赖性方式降低 LPS 诱导的血清 IL-6 和 MCP-1 水平 (10, 100 mg/kg; p.o.)。 |
| 分子式 | C26H36N6O2S |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容